Response of choriocarcinoma to paclitaxel. Case report and review of resistance

European Journal of Gynaecological Oncology

Volumn 18, Issue 2, 1997, Pages 108-110

  Gerson C, R ^a   Serrano O, A ^b   Del Carmen Bello, M ^a   Lazaro L, M ^a   Kudelka, A P ^c   Kavanagh, J J ^c  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b AMERICAN BRITISH COWDRAY MEDICAL CENTER   (Mexico)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Choriocarcinoma; Paclitaxel; Resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORIOCARCINOMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PROGNOSIS; REMISSION; TROPHOBLASTIC DISEASE;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHORIOCARCINOMA; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; PACLITAXEL; PREGNANCY; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 0030897516     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Parness J., Horwitz S.: "Taxol binds to polymerized tubulin in vitro". J. Cell. Biol., 1981, 91, 479.
2. Rowinsky E. K., Donehower R. C.: "The clinical pharmacology of paclitaxel (Taxol)". Semin. Oncol., 1993, 20, 16.
3. Pazdur P., Kudelka A. P., Kavanagh J. J., Cohen P. R., Raber M.N.: "The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere)". Cancer Treat. Rev., 1993, 198, 351.
4. Seidman A. D., Norton L., Reichman B. S. et al.: "Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony stimuling factor in treatment of breast cancer". Semin. Oncol., 1993, 20 (4) (Suppl. 3), 40.
5. Ettinger D. S.: "Overview of paclitaxel (Taxol) in advanced lung cancer". Semin. Oncol., 1993, 20 (4) (Suppl. 3), 46.
6. Caldas C., McGuire W. P. III: "Paclitaxel (Taxol) therapy in ovarian carcinoma". Semin. Oncol., 1993, 20 (4) (Suppl. 3), 50.
7. Rowinsky E. K., Donehower R. C.: "Paclitaxel (Taxol)". N. Engl. J. Med., 1995, 332 (15), 1004.
8. Holmes F. A., Kudelka A. P., Kavanagh J. J., Huber M. H., Ajani J. A., Valero V.: "Current status of clinical trials with paclitaxel and docetaxel" Am. Chem. Society, 1995, 31.
9. Marth C., Lang T., Widschwendter M. et al.: "Effects to taxol in choriocarcinoma cells". Am. J. Obstet. Gynecol., 1995, (in press).
10. Koechli O. R., Schaer G. N., Sevin B. U. et al.: "In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms". Anti-Cancer Drugs, 1995, 6, 94.
11. Horwitz S. B., Cohen D., Rao S. et al.: "Taxol: mechanisms of action and resistance monographs". Natl. Cancer Inst., 1993, 15, 55.
12. Gerson R. et al.: "Etoposido Y cisplatino en pacientes con neoplasia trofoblastica gestacional en etapas avanzadas". Revista Medica del Hospital General. 1995, 58 (1), 5.
13. Bagshawe K. D.: "Trophoblastic tumors, diagnostics methods, epidemiology, clinical features and management". In: Copplesson M. Monaghan J. M., Morrow C. P., Tattersall M. H. N., eds Gynaecol Oncol., London. UK. Churchill Livingstone, 1992, 2a, 1027.
14. Cohen D. Higman S. M., Hong Hsu S. L., Horwitz S. B.: "The involvement of a line-1 element in a DNA rearrangement upstream of the mdr 1a gene in a taxol multidrug-resistance murine cell line". J. Biol. Chemistry, 1992, 267 (28), 20248.
15. Greenberg L. M., Williams S. S., Horwitz S. B.: "Biosynthesis of heterogeneous form of multidrugs resistance-associated glycoproteins". J. Biol. Chemistry, 1987, 262 (28), 13685.
16. Roy S. N., Horwitz S. B.: "A phosphoglycoprotein associated with taxol resistance in J774.2 cells". Cancer Res., 1985, 45, 3856.
17. Murren J R., De Vita V. T.: "Another look at multidrug resistance". PPO updates, 1995, 9 (11), 1.
18. Cardarelli C., Aksentijevitch I., Pastan I. et al.: "Differential effects of p-glycoprotein inhibitors on NIH 3T3 cells transefected with wildtype (G185) or mutant (V185) multidrug transporters". Cancer Res., 1990, 50, 1748.
19. Lehnert M., Emerson S., Dalton W. S., de Giuli R., Salmon S. E.: "In vitro evaluation of chemosensitizers for clinical reversal of P-glycoprotein-associated taxol resistance". J. Natl. Cancer Inst., 1993, 15, 63.
20. Schibler M. J., Cabral F.: "Taxol-dependent mutants of Chinese hamster ovary cells3 with alterations in α- and β- tubulin". J. Cell Biol., 1986, 102, 1552
21. Minotti A. M., Barlow S. B., Cagral F.: "Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin". J. Biol. Chem., 1991, 266, 3987.